Recent Updates
Recently added Catalysts
AARD Negative Sentiment

Shareholders who lost money in shares of acquired Aardvark Therapeutics, Inc. (NASDAQ: AARD) should contact Wolf Haldenstein Immediately

Key Takeaway: The article addresses the financial losses suffered by shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD) following its acquisition. It urges these shareholders to contact the law firm Wolf Haldenstein for assistance. The focus is on the potential for legal recourse for those impacted by the acquisition.

Market Sentiment Analysis

CONCERNS & RISKS

  • Shareholders of Aardvark Therapeutics have incurred financial losses.
  • The article suggests that affected shareholders should take immediate action.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+127%
120-day peak, hindsight
Typical move
4.8%
average across 2 past catalysts
Cash runway
~12 mo
Low dilution risk
Lead asset
ARD-101
Phase 2 · Bariatric Surgery

Full Press Release Details

Accessibility Statement Skip Navigation Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact Search Search When typing in this field, a list of search results will appear and be automatically updated as you type. Searching for your content... No results found. Please change your search terms and try again. News in Focus Browse News Releases All News Releases All Public Company English-only News Releases Overview Multimedia Gallery All Multimedia All Photos All Videos Multimedia Gallery Overview Trending Topics All Trending Topics Business & Money Auto & Transportation All Automotive & Transportation Aerospace, Defense Air Freight Airlines & Aviation Automotive Maritime & Shipbuilding Railroads and Intermodal Transportation Supply Chain/Logistics Transportation, Trucking & Railroad Travel Trucking and Road Transportation Auto & Transportation Overview View All Auto & Transportation Business Technology All Business Technology Blockchain Broadcast Tech Computer & Electronics Computer Hardware Computer Software Data Analytics Electronic Commerce Electronic Components Electronic Design Automation Financial Technology High Tech Security Internet Technology Nanotechnology Networks Peripherals Semiconductors Business Technology Overview View All Business Technology Entertain­ment & Media All Entertain­ment & Media Advertising Art Books Entertainment Film and Motion Picture Magazines Music Publishing & Information Services Radio & Podcast Television Entertain­ment & Media Overview View All Entertain­ment & Media Financial Services & Investing All Financial Services & Investing Accounting News & Issues Acquisitions, Mergers and Takeovers Banking & Financial Services Bankruptcy Bond & Stock Ratings Conference Call Announcements Contracts Cryptocurrency Dividends Earnings Earnings Forecasts & Projections Financing Agreements Insurance Investments Opinions Joint Ventures Mutual Funds Private Placement Real Estate Restructuring & Recapitalization Sales Reports Shareholder Activism Shareholder Meetings Stock Offering Stock Split Venture Capital Financial Services & Investing Overview View All Financial Services & Investing General Business All General Business Awards Commercial Real Estate Corporate Expansion Earnings Environmental, Social and Governance (ESG) Human Resource & Workforce Management Licensing New Products & Services Obituaries Outsourcing Businesses Overseas Real Estate (non-US) Personnel Announcements Real Estate Transactions Residential Real Estate Small Business Services Socially Responsible Investing Surveys, Polls and Research Trade Show News General Business Overview View All General Business Science & Tech Consumer Technology All Consumer Technology Artificial Intelligence Blockchain Cloud Computing/Internet of Things Computer Electronics Computer Hardware Computer Software Consumer Electronics Cryptocurrency Data Analytics Electronic Commerce Electronic Gaming Financial Technology Mobile Entertainment Multimedia & Internet Peripherals Social Media STEM (Science, Tech, Engineering, Math) Supply Chain/Logistics Wireless Communications Consumer Technology Overview View All Consumer Technology Energy & Natural Resources All Energy Alternative Energies Chemical Electrical Utilities Gas General Manufacturing Mining Mining & Metals Oil & Energy Oil and Gas Discoveries Utilities Water Utilities Energy & Natural Resources Overview View All Energy & Natural Resources Environ­ment All Environ­ment Conservation & Recycling Environmental Issues Environmental Policy Environmental Products & Services Green Technology Natural Disasters Environ­ment Overview View All Environ­ment Heavy Industry & Manufacturing All Heavy Industry & Manufacturing Aerospace & Defense Agriculture Chemical Construction & Building General Manufacturing HVAC (Heating, Ventilation and Air-Conditioning) Machinery Machine Tools, Metalworking and Metallurgy Mining Mining & Metals Paper, Forest Products & Containers Precious Metals Textiles Tobacco Heavy Industry & Manufacturing Overview View All Heavy Industry & Manufacturing Telecomm­unications All Telecomm­unications Carriers and Services Mobile Entertainment Networks Peripherals Telecommunications Equipment Telecommunications Industry VoIP (Voice over Internet Protocol) Wireless Communications Telecomm­unications Overview View All Telecomm­unications Lifestyle & Health Consumer Products & Retail All Consumer Products & Retail Animals & Pets Beers, Wines and Spirits Beverages Bridal Services Cannabis Cosmetics and Personal Care Fashion Food & Beverages Furniture and Furnishings Home Improvement Household, Consumer & Cosmetics Household Products Jewelry Non-Alcoholic Beverages Office Products Organic Food Product Recalls Restaurants Retail Supermarkets Toys Consumer Products & Retail Overview View All Consumer Products & Retail Entertain­ment & Media All Entertain­ment & Media Advertising Art Books Entertainment Film and Motion Picture Magazines

Frequently Asked Questions

What should Aardvark Therapeutics shareholders do?

Shareholders who lost money should contact Wolf Haldenstein for assistance.

Why are shareholders of Aardvark Therapeutics concerned?

They are concerned due to financial losses incurred from the acquisition.

Last updated: Sep 2, 2026